Synergy Pharmaceuticals to Spin-Off FV-100 Assets
August 08, 2013 at 20:25 PM EDT
Synergy Pharmaceuticals Inc. (NASDAQ: SGYP ), a developer of new drugs to treat gastrointestinal diseases and disorders, today announced the planned spin-off of its FV-100 assets into a separate publicly traded
